Optimum Strategic Communications

14th Annual Healthcare Investor Conference

Thursday, 6th October 2022

Wellcome Collection, London

Discover the EventRSVP


Join Optimum Strategic Communications on Thursday, 6th October 2022 for our Annual Investor Healthcare Conference.

Now in its 14th year, the conference is now firmly established as a major thought leadership event in Europe, bringing together the top executives and visionaries from the healthcare industry and investment community to discuss and debate the trends set to reshape the industry far into the future.

We are thrilled to be returning to an in-person event this year, taking place at the Wellcome Collection, London.


Reviews from our past speakers on what makes Optimum's Healthcare Investor Conference unique.

2022 Speakers

Leading speakers from the healthcare and investment communities providing insights on the latest trends and impacts on the industry.

Past Speakers

A selection of some of our brilliant panellists from previous years.

  • Dan Mahony Dan Mahony Polar Capital
  • Kieran Murphy Kieran Murphy GE Healthcare
  • Mary Clark Mary Clark Optimum Strategic Communications
  • Oliver Maier Oliver Maier Bayer
  • Clive Cookson Clive Cookson Financial Times
  • Kate Bingham Kate Bingham UK Vaccine Taskforce, SV Health Investors
  • James Logan Professor James Logan The London School of Hygience and Tropical Medicine
  • Rajeev Venkayya Rajeev Venkayya Takeda Pharmaceuticals
  • Sean Marett Sean Marett BioNTech
  • Peter Stein Peter Stein Norgine Group
  • Mike Ward Mike Ward Decision Resources Group, part of Clarivate
  • Elisa Petris Elisa Petris Syncona
  • Guillaume Vignon Guillaume Vignon BeiGene
  • Linden Thomson Linden Thomson AXA Investment Managers
  • Philippe Lopes-Fernandes Philippe Lopes-Fernandes Ipsen
  • Kevin Mannix Kevin Mannix Teva Pharmaceutical Industries Ltd
  • Stavros Mercouris Stavros Mercouris KKR
  • Isabella Eichler Isabella Eichler Altor Private Equity
  • Kasim Kutay Kasim Kutay Novo Holdings
  • Werner Lanthaler Werner Lanthaler Evotec
  • Anne Marden Anne Marden JP Morgan Asset Management
  • Jan van de Winkel Jan van de Winkel Genmab
  • Geraldine O'Keeffe Geraldine O'Keeffe LSP
  • Antoine Papiernik Antoine Papiernik Sofinnova Partners
  • Martin Murphy Martin Murphy Syncona
  • Edwin Moses Edwin Moses NED Various
  • Annalisa Jenkins Annalisa Jenkins NED Various
  • Paul Major Paul Major Bellevue Asset Management
  • Professor Tony Young OBE Professor Tony Young OBE NHS England
  • Roel Bulthuis Roel Bulthuis Inkef Capital
  • David Pinniger David Pinniger Polar Capital
  • Vicky Darbyshire Vicky Darbyshire JP Morgan Asset Management
  • Hakan Goker Hakan Goker M Ventures
  • George Freeman George Freeman Government adviser on Life Sciences
  • Catherine Pickering Catherine Pickering iOnctura
  • Gavin MacGregor Gavin MacGregor HBM Partners
  • Andrew Holder Andrew Holder Mole Valley Asset Management
  • Richard Girling Richard Girling Centreview Partners
  • Justin Stebbing Justin Stebbing Imperial College London
  • Deborah Harland Deborah Harland SR One
  • Lisa Urquhart Lisa Urquhart Vantage
  • Thomas Burt Thomas Burt Sofinnova
  • Harry Destecroix Harry Destecroix Unit DX
  • Ilan Chaitowitz Ilan Chaitowitz Nomura Asset Management
  • Dale Raine Dale Raine Lazard
  • Jonathan Tobin Jonathan Tobin Arix Bioscience
  • Soren Moller Soren Moller Novo Holdings
  • Jasper Bos Jasper Bos M Ventures
  • Marc Booty Marc Booty Pictet Asset Management
  • Eva Haas Eva Haas Optimum Strategic Communications
  • Ian Nicholson Ian Nicholson F2G
  • Anker Lundemose Anker Lundemose Mission Therapeutics
  • Sam Fazeli Sam Fazeli Bloomberg Intelligence
  • Professor Sir Michael Rawlins Professor Sir Michael Rawlins NICE
  • Andy Richards CBE Andy Richards CBE NED Various
  • Rice Powell Rice Powell Fresenius Medical Care
  • Renee Aguiar-Lucander Renee Aguiar-Lucander Calliditas Therapeutics
  • John Dawson John Dawson Oxford Biomedica
  • Lisa Anson Lisa Anson Redx Pharma
  • Francesco de Rubertis Francesco de Rubertis Medicxi
  • Amber Tong Amber Tong Endpoints News
  • Ulrica Slåne Bjerke Ulrica Slåne Bjerke Arctic Asset Management
  • Maina Bhaman Maina Bhaman Sofinnova Partners


Optimum Strategic Communications

Optimum Strategic Communications

Optimum Strategic Communications is an international healthcare communications firm which specialises in strategic investor relations, corporate and financial communications. Our senior team of healthcare specialists, based in London, Amsterdam, Stockholm, Zurich, and New York, are experienced and trusted advisors to some of the world’s most exciting public and private companies, both large and small, across pharmaceuticals, medtech, biotech, health tech and healthcare services.

Over the last 20 years we have worked with over 300 healthcare companies, advising them on financial communications and investor relations, including major corporate activity such as fundraising, IPOs, and M&A, as well as corporate reputation and crisis scenarios.

We have an exceptional network of contacts across the international investment community in Europe and the US; contacts we have built and maintained over the last three decades. Our team includes ex-fund managers and analysts, scientists, as well as financial and corporate communications specialists.

For more information please visit www.optimumcomms.com

2022 Agenda

When & Where

We look forward to welcoming you to our virtual conference.

Optimum’s 14th Healthcare Investor Conference

Wellcome Collection, 183 Euston Road, London, NW1